EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Autophagy with Puerarin: From a Natural Isoflavone to Therapeutic Applications

Wanwan Wang, Yutong Liu, Mingren Qu, Yanjiao Li

Pharmaceuticals · 08.11.2026 · 19 (11) · 1775

DOI: 10.3390/ph19111775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 08.11.2026. Verfasst von Wanwan Wang und 3 weiteren Autor:innen. Die Arbeit nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Young Talents Training Program for Academic and Technical Leaders of Major Disciplines in Jiangxi Province, Natural Science Foundation of Jiangxi Province, China, China Agriculture Research System of MOF and MARA.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autophagy is an evolutionarily conserved lysosomal degradation process that eliminates damaged organelles and misfolded proteins to maintain cellular homeostasis. Its dysfunction drives cancer, neurodegeneration, and cardiovascular, hepatic, renal and skeletal muscle disorders, making autophagy a promising therapeutic target. Puerarin, a characteristic isoflavone from the leguminous medicinal plant Pueraria lobata, exerts broad pharmacological functions via autophagy modulation, yet no systematic review summarizes its tissue-specific regulatory patterns. This narrative review collects and categorizes recent cellular and animal studies on puerarin–autophagy crosstalk from mainstream databases. It organizes puerarin’s bidirectional autophagy effects across multiple organs and summarizes core signaling pathways, including AMPK/mTOR and PI3K/Akt/mTOR. Puerarin exhibits context-dependent dual regulation of autophagy: it induces protective autophagy to relieve metabolic and degenerative organ injuries, while inhibiting excessive autophagy to alleviate fibrosis and tumor progression. Its regulatory roles depend on Nrf2, JNK/Beclin1 and mitophagy-related axes in cardiac, hepatic, pulmonary, renal, bone, muscle and nervous tissues, as well as various tumor models. These mechanistic insights may support the development of natural isoflavone-based therapeutic strategies targeting autophagy and broaden the value-added utilization of Pueraria lobata as a medicinal and agricultural resource.

Förderung

  • Young Talents Training Program for Academic and Technical Leaders of Major Disciplines in Jiangxi Province
  • Natural Science Foundation of Jiangxi Province, China
  • China Agriculture Research System of MOF and MARA

Zitieren

APA

Wang, W., Liu, Y., Qu, M., & Li, Y. (2026). Targeting Autophagy with Puerarin: From a Natural Isoflavone to Therapeutic Applications. Pharmaceuticals, 19(11), 1775. https://doi.org/10.3390/ph19111775

Vancouver

Wang W, Liu Y, Qu M, Li Y. Targeting Autophagy with Puerarin: From a Natural Isoflavone to Therapeutic Applications. Pharmaceuticals. 2026;19(11):1775. doi:10.3390/ph19111775

BibTeX
@article{Wang2026,
  author = {Wang, Wanwan and Liu, Yutong and Qu, Mingren and Li, Yanjiao},
  title = {Targeting Autophagy with Puerarin: From a Natural Isoflavone to Therapeutic Applications},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {11},
  pages = {1775},
  doi = {10.3390/ph19111775}
}
Kostenlos starten →